TrialJournal of the American College of Cardiology2017

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

Joshua M Hare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.